Medium-term Outcomes of Urolift (Minimum 12 Months Follow-up): Evidence From a Systematic Review
2016; Elsevier BV; Volume: 97; Linguagem: Inglês
10.1016/j.urology.2016.05.003
ISSN1527-9995
AutoresPatrick Jones, GN Rajkumar, Bhavan Prasad, Omar M. Aboumarzouk, Paul Cleaveland, Shalom J. Srirangam, Bhaskar Somani,
Tópico(s)Pediatric Urology and Nephrology Studies
ResumoThe urolift device has emerged as a novel intervention for men with lower urinary tract symptoms secondary to benign prostatic hyperplasia, and in recent years there has been an increasing amount of primary research published on it. However, critical medium-term appraisal remains lacking. Our objective was to perform a systematic review and therefore identify, appraise, and synthesize the existing evidence for the minimally invasive technique. The urolift device has emerged as a novel intervention for men with lower urinary tract symptoms secondary to benign prostatic hyperplasia, and in recent years there has been an increasing amount of primary research published on it. However, critical medium-term appraisal remains lacking. Our objective was to perform a systematic review and therefore identify, appraise, and synthesize the existing evidence for the minimally invasive technique.
Referência(s)